# Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-dapagliflozin-on-renal-function-and-outcomes-in-patients-with-heart/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Pardeep S. Jhund,Scott D. Solomon,Kieran F. Docherty,Hiddo J.L. Heerspink,Inder S. Anand,Michael Böhm,Vijay Chopra,Rudolf A. de Boer,Akshay S. Desai,Junbo Ge,Masafumi Kitakaze,Bela Merkley,Eileen O’Meara,Morten Shou,С. Н. Терещенко,Subodh Verma,Pham Nguyễn Vinh,Silvio E. Inzucchi,Lars Køber,Mikhail Kosiborod,Felipe A. Martínez,Piotr Ponikowski,Marc S. Sabatine,Olof Bengtsson,Anna Maria Langkilde,Mikaela Sjöstrand,John J.V. McMurray |
| Citations | 305 |
| DOI | 10.1161/circulationaha.120.050391 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.050391 |
| OpenAlex ID | https://openalex.org/W3092582090 |
| PMID | 33040613 |
| Type | article |
| Year | 2020 |

## Paper authors

Showing 10 of 16.

- [Pardeep S. Jhund](https://scholariq.org/researchers/pardeep-s-jhund/)
- [Inder S. Anand](https://scholariq.org/researchers/inder-s-anand/)
- [Michael Böhm](https://scholariq.org/researchers/michael-bohm/)
- [Piotr Ponikowski](https://scholariq.org/researchers/piotr-ponikowski/)
- [Silvio E. Inzucchi](https://scholariq.org/researchers/silvio-e-inzucchi/)
- [Marc S. Sabatine](https://scholariq.org/researchers/marc-s-sabatine/)
- [Hiddo J.L. Heerspink](https://scholariq.org/researchers/hiddo-j-l-heerspink/)
- [Rudolf A. de Boer](https://scholariq.org/researchers/rudolf-a-de-boer/)
- [Lars Køber](https://scholariq.org/researchers/lars-k-ber/)
- [Mikhail Kosiborod](https://scholariq.org/researchers/mikhail-kosiborod/)

## Paper funders

Showing 8 of 33.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Brigham and Women's Hospital](https://scholariq.org/funders/brigham-and-women-s-hospital/)

## Paper journal

- [Circulation](https://scholariq.org/journals/circulation/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.